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The Authors Reply: We agree with the commentary of
Drs Ghayur and Janssen regarding the importance of
medicinal plants in the treatment of many diseases in
different cultures and ages.1 Moreover, today, medicinal
plants still represent a vast source of new chemical molecules
that continuously promote drug research. However, the
uncontrolled resurgence of these ‘natural products’ observed
today, and promoted by thousands of Internet sites, needs
several caveats: (1) These remedies are often assumed to be
safe (because they are natural). (2) Potential risks associated
with such treatments are only poorly studied or reported. (3)
These remedies are mostly not under the control of a
regulatory system that guarantees a high-quality manufacture
of the product.
The adverse effects of such products may involve direct
risks such as dose-dependent toxicity, idiosyncratic reactions,
teratogenicity, and mutagenicity, and indirect risks when a
conventional treatment is abandoned in favor of the natural
product. Furthermore, interactions between herbal medicines
and conventional drugs may be dangerous and can lead to
severe complications such as in the case of St John’s wort
(Hypericum perforatum) when given with other drugs
metabolized by P450 CYP3A4 (cyclosporine, coumarines).2
In renal medicine, among others,2,3 the most famous medicinal
plant-associated problem is Aristolochic-acid nephropathy
(Aristolochia fangchi), which has led to several cases of
end-stage renal failure all over the world.4
Therefore, research on medicinal plants as a source of new
substances is important; however, in humans, these compo-
nents should be administered only under well-controlled study
conditions. Furthermore, preliminary toxicological experiments
in cell cultures or animals would be desirable when such studies
are planned.
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